Literature DB >> 8498656

Heparin prevents the vasodilating actions of protamine on human small mesenteric arteries.

T Akata1, K Kodama, J Yoshitake, S Takahashi.   

Abstract

Despite the wide clinical use of protamine, the precise mechanisms of its hypotensive effects during reversal of heparin anticoagulation have not been elucidated fully. We, therefore, investigated the effects of protamine on isolated human small mesenteric arteries, both in the absence and presence of heparin, employing the isometric tension recording method. Protamine exerted vasodilating actions in the absence of heparin: 1) protamine (> or = 50 or 150 micrograms/mL) inhibited (P < 0.05) both norepinephrine (1 microM)- and high K+ (40 mM)-induced contractions in the presence of extracellular Ca2+ both in endothelium-intact and -denuded tissues; and 2) protamine inhibited (P < 0.05) norepinephrine (1 microM)-induced, but not caffeine (10 mM)-induced, contractions in the absence of extracellular Ca2+. Such vasodilating actions were blocked almost completely in the presence of heparin. We conclude that only protamine, but not a heparin-protamine complex, has a vasodilating action on the human arteries.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8498656     DOI: 10.1213/00000539-199376060-00006

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  4 in total

1.  Protamine relaxes vascular smooth muscle by directly reducing cytosolic free calcium concentrations in small resistance arteries.

Authors:  Takashi Akata; Kenji Kodama; Alex S Evers; Shosuke Takahashi
Journal:  J Anesth       Date:  1996-12       Impact factor: 2.078

2.  Ketanserin in the treatment of protamine-induced pulmonary hypertension.

Authors:  P J van der Starre; C Solinas
Journal:  Tex Heart Inst J       Date:  1996

3.  Effects of phenol on vascular smooth muscle in rabbit mesenteric resistance arteries.

Authors:  T Akata; K Kodama; S Takahashi
Journal:  J Anesth       Date:  1996-03       Impact factor: 2.078

4.  Cardiovascular and Respiratory Toxicity of Protamine Sulfate in Zebrafish and Rodent Models.

Authors:  Joanna Miklosz; Bartlomiej Kalaska; Piotr Podlasz; Małgorzata Chmielewska-Krzesińska; Miłosz Zajączkowski; Adam Kosiński; Dariusz Pawlak; Andrzej Mogielnicki
Journal:  Pharmaceutics       Date:  2021-03-09       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.